News
Biocon Biologics Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNEâ„¢ (bevacizumab-nwgd), a ...
The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback